UPDATE: Nobel Biocare Net Profit Beats Views, Sales Disappoint
28 Abril 2010 - 3:37AM
Dow Jones News
Nobel Biocare Holding AG (NOBN.VX), the world's largest dental
implant maker by sales, Wednesday reported a better-than-expected
first quarter net profit despite a disappointing sales slowdown but
said it expects dental implant markets to resume growth in
2010.
The Zurich-based company said net profit for the three months to
the end of March rose to EUR38.7 million from EUR18 million a year
earlier. The figure beat estimates for a bottom line result of
EUR22 million as Nobel benefited from cost-cutting and currency
hedging gains.
Sales, however, fell as the company, which is the biggest player
in the U.S., faced challenging dental implant markets in the
U.S.--especially in California and Florida--, Sweden and
Germany.
Overall revenue fell 7.1% in constant currency terms to EUR136.7
million from EUR147 million a year earlier. Sales in North America
dropped 6.7% to EUR44.5 million.
Analysts had hoped that overall sales would remain flat and that
U.S. sales figures would show first signs of sustainable
improvements after competitors such as U.S. Zimmer Holdings Inc
(ZMH), closely held Biomet Inc (BMET) and Swiss peer Straumann
holding AG (STRM.EB) reported rising sales during the January to
March period.
"The dental implant market continued to be challenging in most
regions. Our first quarter result was disappointing," said Chief
Executive Domenico Scala. "But with our recent restructuring and
product launches, we hope to close the sales gap to our
competitors," he said, adding that improvements in markets such as
Spain, Italy and France as well as in some U.S. regions such as the
central U.S., the dental implant market may resume growth in
2010.
Web Site: www.nobelbiocare.com
-By Goran Mijuk, Dow Jones Newswires, +41 43 443 80 47;
goran.mijuk@dowjones.com
Biomet (NASDAQ:BMET)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Biomet (NASDAQ:BMET)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Biomet (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Biomet Inc. (Delisted 9/26/07)